Alphabet’s health tech subsidiary Verily used the health data of more than 25,000 patients without authorization and actively covered up those violations, a former company executive alleges.
The executive, Ryan Sloan, claims Verily fired him after he discovered breaches of the Health Insurance Portability and Accountability Act, or HIPAA, and reported his concerns to the company’s senior management.
Patient data in the U.S. is protected under HIPAA, which ensures the sensitive information cannot be disclosed without a patient’s consent.
Sloan’s allegations are detailed in a pending lawsuit in federal court in San Francisco. The suit, which was filed late last year, has not been previously reported.
On Monday, the judge overseeing Sloan’s case denied a request by Verily to dismiss his civil complaint, or to send the dispute to arbitration.
“Verily believes the allegations and contentions alleged in this employment matter that was commenced in 2023 are completely without merit. Verily will defend itself to the full extent of the law,” a company spokesperson told CNBC in a statement. “Verily is an equal opportunity employer, and takes its responsibility and commitment to abide by all laws and regulations seriously. As this is an ongoing legal matter, Verily will not be providing further comment at this time.”
Representatives for Sloan did not comment.
Verily started as a moonshot in 2015 within Alphabet’s innovation lab X, formerly known as Google X. It’s Google’s sister company and operates under Alphabet’s “Other Bets” category.
The company hired Sloan in 2020 to serve as the chief commercial officer of its diabetes and hypertension business, Verily Onduo.
In January 2022, Sloan alleged that he and Julia Feldman, Onduo’s general counsel, discovered Verily had improperly used patients’ protected health information in its research, marketing campaigns, press releases and national conferences. The “extensive violations” affected more than 25,000 patients in Onduo’s diabetes program, according to an amended complaint filed in June.
Sloan and Feldman informed senior Verily leaders of their findings, the filing said, and they repeatedly raised the issue. An internal investigation at Verily confirmed several HIPAA breaches took place, according to the filing.
“Between January and March of 2022, internal investigators at Verily confirmed multiple breaches of fourteen (14) separate HIPAA Business Associate Agreements with large, covered entity clients of Onduo between 2017 and 2021,” the filing said.
Patients who accessed Verily Onduo through these clients – which include Walgreens Boots Alliance, Highmark Health, Quest Diagnostics and Delta Air Lines, among others – may have been affected by the breaches.
Delta said in a statement that it doesn’t have a comment on the suit, “but our employee’s personal information is important to us.”
“We are looking into this and will make sure any impact to our people is appropriately addressed,” the company said.
Quest said in a statement that, “We are not familiar with the allegations and have no further comment.”
Highmark declined to comment. Walgreens did not respond to CNBC’s requests for comment.
Under HIPAA, companies like Verily are supposed to notify impacted parties no later than 60 days after discovering a breach. Verily “decided to delay the decision of notifying the covered entities,” according to the filing, and the company engaged in negotiations to renew many of those contracts “without revealing that a HIPAA breach had recently occurred.”
“During a contract negotiation between Verily and Highmark Health in August of 2022, Verily represented that it was in compliance with HIPAA at all times, while knowingly concealing that a HIPAA breach had occurred,” the filing said.
That same month, Verily terminated Feldman and another employee who was aware of the breaches.
When Sloan reiterated his concerns about the breaches to Lisa Greenbaum, Verily’s then chief revenue officer, in October 2022, she allegedly defended the company’s decision not to disclose them and said that doing so would negatively affect public relations, the filing said.
Greenbaum joined Doximity, another health-care technology company, as chief commercial officer in January 2024, according to her LinkedIn.
Doximity did not immediately respond to request for comment.
In November 2022, Verily allegedly suppressed a press release out of concern that it would draw attention to previous marketing studies that violated its HIPAA Business Associate Agreements. The company removed the press release from its website and instructed employees not to mention it again, according to the filing.
Sloan was officially terminated from Verily in January of 2023, while on protected leave to care for his “critically ill mother,” the filing said.
The lawsuit marks the latest in a series of stumbles at Verily, which, despite raising more than $1 billion from investors, has struggled to latch onto a winning product. Verily is reportedly transitioning from a Limited Liability Company, or an LLC, to an investor-friendly C-corp structure to prepare for a fresh round of funding, according to a report from Business Insider on Wednesday.
Verily originally developed hardware like continuous glucose monitors before pivoting to pandemic response when Covid-19 broke out in 2020, then switched directions again to focus on precision health in 2022.
The company introduced a new artificial intelligence-powered chronic care solution called Verily Lightpath last year, and announced it was selling its stop-loss insurance subsidiary, Granular Insurance Company, in February.
–CNBC’s Lora Kolodny and Dan Mangan contributed to this report
Xpeng CEO He Xiaopeng speaks to reporters at the electric carmaker’s stand at the IAA auto show in Munich, Germany on September 8, 2025.
Arjun Kharpal | CNBC
Germany this week played host to one of the world’s biggest auto shows — but in the heartland of Europe’s auto industry, it was buzzy Chinese electric car companies looking to outshine some of the region’s biggest brands on their home turf.
The IAA Mobility conference in Munich was packed full of companies with huge stands showing off their latest cars and technology. Among some of the biggest displays were those from Chinese electric car companies, underscoring their ambitions to expand beyond China.
Europe has become a focal point for the Asian firms. It’s a market where the traditional automakers are seen to be lagging in the development of electric vehicles, even as they ramp up releases of new cars. At the same time, Tesla, which was for so long seen as the electric vehicle market leader, has seen sales decline in the region.
Despite Chinese EV makers facing tariffs from the European Union, players from the world’s second-largest economy have responded to the ramping up of competition by setting aggressive sales and expansion targets.
“The current growth of Xpeng globally is faster than we have expected,” He Xiaopeng, the CEO of Xpeng told CNBC in an interview this week.
Aggressive expansion plans
Chinese carmakers who spoke to CNBC at the IAA show signaled their ambitious expansion plans.
Xpeng’s He said in an interview that the company is looking to launch its mass-market Mona series in Europe next year. In China, Xpeng’s Mona cars start at the equivalent of just under $17,000. Bringing this to Europe would add some serious price competition.
Meanwhile, Guangzhou Automobile Group (GAC) is targeting rapid growth of its sales in Europe. Wei Haigang, president of GAC International, told CNBC that the company aims to sell around 3,000 cars in Europe this year and at least 50,000 units by 2027. GAC also announced plans to bring two EVs — the Aion V and Aion UT — to Europe. Leapmotor was also in attendance with their own stand.
There are signs that Chinese players have made early in roads into Europe. The market share of Chinese car brands in Europe nearly doubled in the first half of the year versus the same period in 2024, though it still remains low at just over 5%, according to Jato Dynamics.
“The significant presence of Chinese electric vehicle (EV) makers at the IAA Mobility, signals their growing ambitions and confidence in the European market,” Murtuza Ali, senior analyst at Counterpoint Research, told CNBC.
Tech and gadgets in focus
Many of the Chinese car firms have positioned themselves as technology companies, much like Tesla, and their cars highlight that.
Many of the electric vehicles have big screens equipped with flashy interfaces and voice assistants. And in a bid to lure buyers, some companies have included additional gadgets.
For example, GAC’s Aion V sported a refrigerator as well as a massage function as part of the seating.
The Aion V is one of the cars GAC is launching in Europe as it looks to expand its presence in the region. The Aion V is on display at the company’s stand at the IAA Mobility auto show in Munich, Germany on September 9, 2025.
Arjun Kharpal | CNBC
This is one way that the Chinese players sought to differentiate themselves from legacy brands.
“The chances of success for Chinese automakers are strong, especially as they have an edge in terms of affordability, battery technology, and production scale,” Counterpoint’s Ali said.
Europe’s carmakers push back
Legacy carmakers sought to flex their own muscles at the IAA with Volskwagen, BMW and Mercedes having among the biggest stands at the show. Mercedes in particular had advertising displayed all across the front entrance of the event.
BMW, like the Chinese players, had a big focus on technology by talking up its so-called “superbrain architecture,” which replaces hardware with a centralized computer system. BMW, which introduced the iX3 at the event, and chipmaker Qualcomm also announced assisted driving software that the two companies co-developed.
Volkswagen and French auto firm Renault also showed off some new electric cars.
Regardless of the product blitz, there are still concerns that European companies are not moving fast enough. BMW’s new iX3 is based on the electric vehicle platform it first debuted two years ago. Meanwhile, Chinese EV makers have been quick in bringing out and launching newer models.
“A commitment to legacy structures and incrementalism has slowed its ability to build and leverage a robust EV ecosystem, leaving it behind fast moving rivals,” Tammy Madsen, professor of management at the Leavey School of Business at Santa Clara University, said of BMW.
While European autos have a strong brand history and their CEOs acknowledged and welcomed the competition this week in interviews with CNBC, the Chinese are not letting up.
“Europe’s automakers still hold significant brand value and legacy. The challenge for them lies in achieving production at scale and adopting new technologies faster,” Counterpoint’s Ali said.
“The Chinese surely are not waiting for anyone to catch-up and are making significant gains.”
OpenAI on Friday introduced a new program, dubbed the “OpenAI Grove,” for early tech entrepreneurs looking to build with artificial intelligence, and applications are already open.
Unlike OpenAI’s Pioneer Program, which launched in April, Grove is aimed towards individuals at the very nascent phases of their company development, from the pre-idea to pre-seed stage.
For five weeks, participants will receive mentoring from OpenAI technical leaders, early access to new tools and models, and in-person workshops, located in the company’s San Francisco headquarters.
Roughly 15 members will join Grove’s first cohort, which will run from Oct. 20 to Nov. 21, 2025. Applicants will have until Sept. 24 to submit an entry form.
CNBC has reached out to OpenAI for comment on the program.
Following the program, Grove participants will be able to continue working internally with the ChatGPT maker, which was recent valued $500 billion.
Nurturing these budding AI companies is just a small chip in the recent massive investments into AI firms, which ate up an impressive 71% of U.S. venture funding in 2025, up from 45% last year, according to an analysis from J.P. Morgan.
AI startups raised $104.3 billion in the U.S. in the first half of this year, and currently over 1,300 AI startups have valuations of over $100 million, according to CB Insights.
The co-founder and CEO of sales and customer service management software company Salesforce is well aware that investors are betting big on Palantir, which offers data management software to businesses and government agencies.
“Oh my gosh. I am so inspired by that company,” Benioff told CNBC’s Morgan Brennan in a Tuesday interview at Goldman Sachs‘ Communacopia+Technology conference in San Francisco. “I mean, not just because they have 100 times, you know, multiple on their revenue, which I would love to have that too. Maybe it’ll have 1000 times on their revenue soon.”
Salesforce, a component of the Dow Jones Industrial Average, remains 10 times larger than Palantir by revenue, with over $10 billion in revenue during the latest quarter. But Palantir is growing 48%, compared with 10% for Salesforce.
Benioff added that Palantir’s prices are “the most expensive enterprise software I’ve ever seen.”
“Maybe I’m not charging enough,” he said.
Read more CNBC tech news
It wasn’t Benioff’s first time talking about Palantir. Last week, Benioff referenced Palantir’s “extraordinary” prices in an interview with CNBC’s Jim Cramer, saying Salesforce offers a “very competitive product at a much lower cost.”
The next day, TBPN podcast hosts John Coogan and Jordi Hays asked for a response from Alex Karp, Palantir’s co-founder and CEO.
“We are very focused on value creation, and we ask to be modestly compensated for that value,” Karp said.
The companies sometimes compete for government deals, and Benioff touted a recent win over Palantir for a U.S. Army contract.
Palantir started in 2003, four years after Salesforce. But while Salesforce went public in 2004, Palantir arrived on the New York Stock Exchange in 2020.
Palantir’s market capitalization stands at $406 billion, while Salesforce is worth $231 billion. And as one of the most frequently traded stocks on Robinhood, Palantir is popular with retail investors.
Salesforce shares are down 27% this year, the worst performance in large-cap tech.